Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Boussard & Gavaudan Investment Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Boussard & Gavaudan Investment Management
from 13F filings
Historical chart of Boussard & Gavaudan Investment Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Boussard & Gavaudan Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $22M | 13k | 1644.56 |
| 2024-12-31 | $7.0M | 6.5k | 1072.24 |
| 2024-09-30 | $12M | 11k | 1173.38 |
More positions owned by Boussard & Gavaudan Investment Management
View all positions for Boussard & Gavaudan Investment Management
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1